Alembic Pharma gets USFDA OK for Pregabalin capsules from Jarod unit

Alembic Pharma gets USFDA OK for Pregabalin capsules from Jarod unit

Pregabalin capsules are used to treat epilepsy, anxiety, and other indications. The drug is therapeutically equivalent of Lyrica capsules owned by Upjohn

FPJ Web DeskUpdated: Thursday, December 22, 2022, 04:21 PM IST
article-image
Image credit: Wikipedia (Representative)

The US Food and Drug Administration approves Alembic Pharmaceuticals Ltd to produce Pregabalin capsules at its Jarod facility, the company announced today.

According to Alembic Pharmaceuticals, this is the first product approval the company has obtained from the Jarod facility.

Alembic Pharma had filed the application with US regulator under the Prior Approval Supplement category, which allows drugmakers to shift their manufacturing base to the new production facility. The company had approval to make this product at its Panelav facility.

USFDA conducted an inspection at the Jarod facility earlier this month.

Pregabalin capsules are used to treat epilepsy, anxiety, and other indications. The drug is therapeutically equivalent of Lyrica capsules owned by Upjohn.

It has an estimated market size of $244 mln for the year ending Sep, the company said, quoting IQVIA data.

RECENT STORIES

Cipla To Enter India’s Weight Management Market, Strengthens CNS & AMR Focus

Cipla To Enter India’s Weight Management Market, Strengthens CNS & AMR Focus

NLC India In Final Talks With Russian PSU For Lithium Sourcing, Eyes Mali Mine Stake In Africa

NLC India In Final Talks With Russian PSU For Lithium Sourcing, Eyes Mali Mine Stake In Africa

India, US Inch Closer To Interim Trade Pact, Tariff Uncertainty Looms Amid Key Unresolved Issues

India, US Inch Closer To Interim Trade Pact, Tariff Uncertainty Looms Amid Key Unresolved Issues

Top 8 Indian Firms Lose ₹2.07 Lakh Crore In Value, TCS & Airtel Take The Biggest Hit

Top 8 Indian Firms Lose ₹2.07 Lakh Crore In Value, TCS & Airtel Take The Biggest Hit

Q1 Results, India-US Trade Talks In Focus, Inflation Data & Global Trends To Guide Markets

Q1 Results, India-US Trade Talks In Focus, Inflation Data & Global Trends To Guide Markets